{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T20:16:15Z","timestamp":1790021775828,"version":"4.0.1"},"update-to":[{"DOI":"10.1002\/14651858.cd003196","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2013,10,17]],"date-time":"2013-10-17T00:00:00Z","timestamp":1381968000000}}],"reference-count":79,"publisher":"Wiley","issue":"10","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd003196.pub2","type":"journal-article","created":{"date-parts":[[2013,10,17]],"date-time":"2013-10-17T06:30:35Z","timestamp":1381991435000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":78,"title":["Valproic acid, valproate and divalproex in the maintenance treatment of bipolar disorder"],"prefix":"10.1002","volume":"2013","author":[{"given":"Andrea","family":"Cipriani","sequence":"first","affiliation":[{"name":"University of Oxford; Department of Psychiatry; Warneford Hospital Oxford UK OX3 7JX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith","family":"Reid","sequence":"additional","affiliation":[{"name":"Northumberland Tyne and Wear NHS Foundation Trust; Bamburgh Clinic; Jubilee Road Newcastle UK NE3 3XT"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan H","family":"Young","sequence":"additional","affiliation":[{"name":"Imperial College London; Division of Brain Sciences, Centre for Mental Health; London UK W6 8RP"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karine","family":"Macritchie","sequence":"additional","affiliation":[{"name":"University of Edinburgh; Division of Psychiatry; Royal Edinburgh Hospital Edinburgh UK EH10 5HF"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Geddes","sequence":"additional","affiliation":[{"name":"University of Oxford\/Warneford Hospital; Department of Psychiatry; Oxford UK OX3 7JX"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2013,10,17]]},"reference":[{"key":"10.1002\/14651858.CD003196.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1097\/01.jcp.0000132344.35713.5f","article-title":"Comparative evaluation of olanzapine efficacy in the maintenance treatment of bipolar disorder","volume":"24","author":"Altamura","year":"2004","journal-title":"Journal of Clinincal Psychopharmacology"},{"issue":"9712","key":"10.1002\/14651858.CD003196.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0140-6736(09)61828-6","article-title":"Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open-label trial","volume":"375","author":"Geddes","year":"2010","journal-title":"Lancet"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD003196.pub2-BIB0004|cit3","first-page":"58","article-title":"Update on the progress of BALANCE","volume":"7","author":"Geddes","year":"2005","journal-title":"Abstracts of the Sixth International Conference on Bipolar Disorder, 16-18 June 2005, Pittsburgh, Pennsylvania, USA. Bipolar Disorders"},{"issue":"1","key":"10.1002\/14651858.CD003196.pub2-BIB0003|cit4","first-page":"48","article-title":"BALANCE: a large simple trial of maintenance treatment for bipolar disorder","volume":"1","author":"Geddes","year":"2002","journal-title":"World Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD003196.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1046\/j.1399-5618.2003.00088.x","article-title":"Developing the BALANCE trial\u2014the role of the pilot study and start-up phase","volume":"6","author":"Rendell","year":"2004","journal-title":"Bipolar Disorders"},{"issue":"5","key":"10.1002\/14651858.CD003196.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1001\/archpsyc.57.5.481","article-title":"A randomised placebo-controlled 12 month trial of divalproex and lithium in the treatment of outpatients with bipolar I disorder","volume":"57","author":"Bowden","year":"2000","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD003196.pub2-BIB0007|cit7","unstructured":"Gyulai L Bowden CL Calabrese JR McElroy SL Petty F Risch SC Efficacy of divalproex for bipolar depression 153rd Annual Meeting of the American Psychiatric Association, 2000 May 13-18, Chicago, IL NR464"},{"issue":"11","key":"10.1002\/14651858.CD003196.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1176\/appi.ajp.162.11.2152","article-title":"A 20-month, double-blind, maintenance trial of lithium versus divalproex in rapid-cycling bipolar disorder","volume":"162","author":"Calabrese","year":"2005","journal-title":"The American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD003196.pub2-BIB0009|cit9","unstructured":"Shelton MD 3rd Rapport DJ Youngstrom EA Elhaj O Bilali SR Findling RL Is rapid cycling a predictor of nonresponse to lithium? 157th Annual Meeting of the American Psychiatric Association; 2004 May 1-6; New York, NY, USA NR759"},{"issue":"5","key":"10.1002\/14651858.CD003196.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/01.chi.0000155981.83865.ea","article-title":"Double-blind 18-month trial of lithium versus divalproex maintenance treatment in pediatric bipolar disorder","volume":"44","author":"Findling","year":"2005","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"issue":"7","key":"10.1002\/14651858.CD003196.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.4088\/JCP.v69n0703","article-title":"Clinical correlates of patients with rapid-cycling bipolar disorder and a recent history of substance use disorder: a subtype comparison from baseline data of 2 randomized, placebo-controlled trials","volume":"69","author":"Gao","year":"2008","journal-title":"Journal of Clinical Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD003196.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"113","DOI":"10.4088\/JCP.07m04022","article-title":"A 6-month, double-blind, maintenance trial of lithium monotherapy versus the combination of lithium and divalproex for rapid-cycling bipolar disorder and co-occurring substance abuse or dependence","volume":"70","author":"Kemp","year":"2009","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD003196.pub2-BIB0013|cit13","unstructured":"Bristol-Myers Squibb Efficacy of aripiprazole in combination with valproate or lithium in the treatment of mania in patients with bipolar I disorder partially nonresponsive to valproate or lithium monotherapy, 2006 http:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT00257972 (accessed 3 October 2013)"},{"issue":"10","key":"10.1002\/14651858.CD003196.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1176\/appi.ajp.2008.07101560","article-title":"Efficacy of adjunctive aripiprazole to either valproate or lithium in bipolar mania patients partially nonresponsive to valproate\/lithium monotherapy: a placebo-controlled study","volume":"165","author":"Vieta","year":"2008","journal-title":"American Journal of Psychiatry"},{"issue":"10","key":"10.1002\/14651858.CD003196.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1176\/appi.ajp.2011.11010163","article-title":"Treatment of suicide attempters with bipolar disorder: a randomized clinical trial comparing lithium and valproate in the prevention of suicidal behavior","volume":"168","author":"Oquendo","year":"2011","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD003196.pub2-BIB0016|cit16","unstructured":"Pfizer A three-week, double-blind, multicenter, placebo-controlled study evaluating the efficacy and safety of add-on oral ziprasidone in subjects with acute mania treated with lithium or divalproex, 2006 http:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT00312494 (accessed 3 October 2013)"},{"issue":"2-3","key":"10.1002\/14651858.CD003196.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jad.2005.01.002","article-title":"Effectiveness and medical costs of divalproex versus lithium in the treatment of bipolar disorder: results of a naturalistic clinical trial","volume":"86","author":"Revicki","year":"2005","journal-title":"Journal of Affective Disorders"},{"issue":"7","key":"10.1002\/14651858.CD003196.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1176\/appi.ajp.160.7.1263","article-title":"Olanzapine versus divalproex sodium for the treatment of acute mania and maintenance of remission: a 47-week study","volume":"160","author":"Tohen","year":"2003","journal-title":"The American Journal of Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD003196.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/j.1600-0447.2012.01890.x","article-title":"Lamotrigine vs. lamotrigine plus divalproex in randomized, placebo-controlled maintenance treatment for bipolar depression","volume":"126","author":"Bowden","year":"2012","journal-title":"Acta psychiatrica Scandinavica"},{"key":"10.1002\/14651858.CD003196.pub2-BIB0020|cit20","unstructured":"Abbott A randomized, double-blind study of depakote monotherapy, olanzapine monotherapy, and combination therapy of depakote plus olanzapine in stable subjects during the maintenance phase of Bipolar Illness ClinicalTrials.gov 2003 http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00071253 (accessed 11 January 2013) [Status of study: terminated]"},{"issue":"11","key":"10.1002\/14651858.CD003196.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1136\/jnnp.2003.029132","article-title":"The longer term outcome of children born to mothers with epilepsy","volume":"75","author":"Adab","year":"2004","journal-title":"Journal of Neurology, Neurosurgery & Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD003196.pub2-BIB0022|cit22","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004848","article-title":"Common antiepileptic drugs in pregnancy in women with epilepsy","author":"Adab","year":"2004","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7066","key":"10.1002\/14651858.CD003196.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1136\/bmj.313.7066.1200","article-title":"Detecting skewness from summary information","volume":"313","author":"Altman","year":"1996","journal-title":"BMJ"},{"issue":"12 Suppl","key":"10.1002\/14651858.CD003196.pub2-BIB0024|cit24","first-page":"1","article-title":"Practice guideline for the treatment of patients with bipolar disorder","volume":"151","author":"American Psychiatric Association","year":"1994","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD003196.pub2-BIB0025|cit25","volume-title":"Diagnostic and Statistical Manual of Mental Disorders. 4th edition, text revision","author":"American Psychiatric Association","year":"2000"},{"issue":"4","key":"10.1002\/14651858.CD003196.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1177\/0004867411435289","article-title":"Borderline personality disorder and bipolar affective disorder. Spectra or spectre? A review","volume":"46","author":"Bassett","year":"2012","journal-title":"Australian & New Zealand Journal of\u00a0Psychiatry"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD003196.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/00004714-199604001-00006","article-title":"Role of newer medications for bipolar disorder","volume":"16","author":"Bowden","year":"1996","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"3","key":"10.1002\/14651858.CD003196.pub2-BIB0028|cit28","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003013","article-title":"Lithium for maintenance treatment of mood disorders","author":"Burgess","year":"2001","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD003196.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1399-5618.2009.00672.x","article-title":"Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD): collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009","volume":"11","author":"Yatham","year":"2009","journal-title":"Bipolar Disorders"},{"issue":"4","key":"10.1002\/14651858.CD003196.pub2-BIB0030|cit30","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004185","article-title":"Fluoxetine versus other types of pharmacotherapy for depression","author":"Cipriani","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7488","key":"10.1002\/14651858.CD003196.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1136\/bmj.330.7488.373","article-title":"Suicide, depression, and antidepressants","volume":"330","author":"Cipriani","year":"2005","journal-title":"British Medical Journal"},{"issue":"2","key":"10.1002\/14651858.CD003196.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1017\/S1121189X00000968","article-title":"Why internal and external validity of experimental studies are relevant for clinical practice?","volume":"18","author":"Cipriani","year":"2009","journal-title":"Epidemiology and Psychiatric Sciences"},{"issue":"3","key":"10.1002\/14651858.CD003196.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1017\/S1121189X00000452","article-title":"What is a randomised controlled trial?","volume":"18","author":"Cipriani","year":"2009","journal-title":"Epidemiol Psichiatr Soc"},{"issue":"4","key":"10.1002\/14651858.CD003196.pub2-BIB0034|cit34","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006117.pub4","article-title":"Sertraline versus other antidepressive agents for depression","author":"Cipriani","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD003196.pub2-BIB0035|cit35","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004367.pub2","article-title":"Olanzapine in long-term treatment for bipolar disorder","author":"Cipriani","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"12","key":"10.1002\/14651858.CD003196.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1177\/0269881109106900","article-title":"Olanzapine in the long-term treatment of bipolar disorder: a systematic review and meta-analysis","volume":"24","author":"Cipriani","year":"2010","journal-title":"Journal of\u00a0Psychopharmacology"},{"issue":"9799","key":"10.1002\/14651858.CD003196.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/S0140-6736(11)60873-8","article-title":"Comparative efficacy and acceptability of antimanic drugs in acute mania: a multiple-treatments meta-analysis","volume":"378","author":"Cipriani","year":"2011","journal-title":"Lancet"},{"issue":"7","key":"10.1002\/14651858.CD003196.pub2-BIB0038|cit38","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006534.pub2","article-title":"Citalopram versus other anti-depressive agents for depression","author":"Cipriani","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"9878","key":"10.1002\/14651858.CD003196.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1016\/S0140-6736(13)60855-7","article-title":"Genetics of bipolar disorder","volume":"381","author":"Craddock","year":"2013","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD003196.pub2-BIB0040|cit40","article-title":"Anti-convulsants","volume-title":"Meyler's Side Effects of Drugs: An Encyclopaedia of Adverse Reactions and Interactions","author":"Dukes","year":"1996"},{"issue":"3 Suppl","key":"10.1002\/14651858.CD003196.pub2-BIB0041|cit41","first-page":"10","article-title":"Valproate use in acute mania and bipolar disorder: an international perspective","volume":"50","author":"Fawcett","year":"1989","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD003196.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1176\/ajp.147.9.1189","article-title":"Time-related predictors of suicide in major affective disorder","volume":"147","author":"Fawcett","year":"1990","journal-title":"American Journal of Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD003196.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1093\/ije\/31.1.72","article-title":"Can we individualize the 'number needed to treat'? An empirical study of summary effect measures in meta-analyses","volume":"31","author":"Furukawa","year":"2002","journal-title":"International Journal of Epidemiology"},{"issue":"11","key":"10.1002\/14651858.CD003196.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1097\/00004583-199611000-00009","article-title":"Hormonal effects of valproic acid?","volume":"35","author":"Garland","year":"1996","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"issue":"9878","key":"10.1002\/14651858.CD003196.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1016\/S0140-6736(13)60857-0","article-title":"Treatment of bipolar disorder","volume":"381","author":"Geddes","year":"2013","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD003196.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/00004583-199801000-00003","article-title":"Valproate and polycystic ovaries","volume":"37","author":"Geller","year":"1998","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"issue":"1-2","key":"10.1002\/14651858.CD003196.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.jad.2009.05.010","article-title":"In-patient care costs of patients with bipolar I disorder: a comparison between two European centers","volume":"121","author":"Gonzalez-Pinto","year":"2010","journal-title":"Journal of Affective Disorders"},{"issue":"4","key":"10.1002\/14651858.CD003196.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1177\/0269881109102919","article-title":"Evidence-based guidelines for treating bipolar disorder: revised second edition\u2014recommendations from the British Association for Psychopharmacology","volume":"23","author":"Goodwin","year":"2009","journal-title":"Journal of Psychopharmacology"},{"key":"10.1002\/14651858.CD003196.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"205\u20138","DOI":"10.1192\/bjp.170.3.205","article-title":"Suicide as an outcome for mental disorders: a meta-analysis","volume":"170","author":"Harris","year":"1997","journal-title":"British Journal of Psychiatry"},{"issue":"12","key":"10.1002\/14651858.CD003196.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"e28725","DOI":"10.1371\/journal.pone.0028725","article-title":"Prescribing trends in bipolar disorder: cohort study in the United Kingdom THIN primary care database 1995-2009","volume":"6","author":"Hayes","year":"2011","journal-title":"PLoS One"},{"issue":"7414","key":"10.1002\/14651858.CD003196.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"British Medical Journal"},{"key":"10.1002\/14651858.CD003196.pub2-BIB0052|cit52","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD003196.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"e124","DOI":"10.1371\/journal.pmed.0020124","article-title":"Why most published research findings are false","volume":"2","author":"Ioannidis","year":"2005","journal-title":"PLoS Medicine"},{"issue":"8310","key":"10.1002\/14651858.CD003196.pub2-BIB0054|cit54","first-page":"1282","article-title":"Sodium valproate and neural tube defects","volume":"2","author":"Jeavons","year":"1982","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD003196.pub2-BIB0055|cit55","first-page":"191","article-title":"The EuroQol instrument: an index of health related quality of life","volume-title":"Spilker B (ed). Quality of Life and Pharmacoeconomics in Clinical Trials","author":"Kind","year":"1996"},{"issue":"5","key":"10.1002\/14651858.CD003196.pub2-BIB0056|cit56","first-page":"707","article-title":"Neuropsychotropic action of a new antiepileptic: depramide","volume":"1","author":"Lambert","year":"1966","journal-title":"Annales Medico-Psychologiques"},{"issue":"3","key":"10.1002\/14651858.CD003196.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1177\/0004867412437346","article-title":"The science and practice of lithium therapy","volume":"46","author":"Malhi","year":"2012","journal-title":"Australian and New Zealand Journal of Psychiatry"},{"key":"10.1002\/14651858.CD003196.pub2-BIB0058|cit58","volume-title":"Prescribing guidelines. The South London and Maudsley NHS Trust","author":"Taylor","year":"2001"},{"issue":"16","key":"10.1002\/14651858.CD003196.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1056\/NEJMoa0803531","article-title":"Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs","volume":"360","author":"Meador","year":"2009","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD003196.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1016\/S0140-6736(96)07495-8","article-title":"Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study","volume":"349","author":"Murray","year":"1997","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD003196.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"241\u20137","DOI":"10.1016\/S0140-6736(02)07450-0","article-title":"Bipolar disorder","volume":"359","author":"M\u00fcller-Oerlinghausen","year":"2002","journal-title":"Lancet"},{"issue":"3","key":"10.1002\/14651858.CD003196.pub2-BIB0062|cit62","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006529.pub2","article-title":"Milnacipran versus other antidepressive agents for depression","author":"Nakagawa","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD003196.pub2-BIB0063|cit63","unstructured":"National Institute of Health and Clinical Excellence (NICE) The management of bipolar disorder in adults, children and adolescents, in primary and secondary care. National Clinical Practice Guideline Number 38 NICE Guidelines 2006"},{"issue":"4","key":"10.1002\/14651858.CD003196.pub2-BIB0064|cit64","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.MR000012.pub3","article-title":"Randomisation to protect against selection bias in healthcare trials","author":"Odgaard-Jensen","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD003196.pub2-BIB0065|cit65","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006114.pub2","article-title":"Fluvoxamine versus other anti-depressive agents for depression","author":"Omori","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD003196.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"78","DOI":"10.7326\/0003-4819-116-1-78","article-title":"A consumer's guide to subgroup analyses","volume":"116","author":"Oxman","year":"1992","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD003196.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"145\u201354","DOI":"10.1016\/j.comppsych.2006.10.001","article-title":"The interface between borderline personality disorder and bipolar spectrum disorders","volume":"48","author":"Paris","year":"2007","journal-title":"Comprehensive Psychiatry"},{"issue":"9878","key":"10.1002\/14651858.CD003196.pub2-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1016\/S0140-6736(13)60989-7","article-title":"Bipolar disorder diagnosis: challenges and future directions","volume":"381","author":"Phillips","year":"2013","journal-title":"Lancet"},{"issue":"Suppl","key":"10.1002\/14651858.CD003196.pub2-BIB0069|cit69","first-page":"3","article-title":"Emerging perspectives on valproate in affective disorders","volume":"50","author":"Post","year":"1989","journal-title":"Journal of Clinical Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD003196.pub2-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/00004714-199604001-00005","article-title":"Bipolar mood disorder: practical strategies for acute and maintenance phase treatment","volume":"16","author":"Sachs","year":"1996","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"1","key":"10.1002\/14651858.CD003196.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/sj.npp.1301575","article-title":"Cellular plasticity cascades in the pathophysiology and treatment of bipolar disorder","volume":"33","author":"Schloesser","year":"2008","journal-title":"Neuropsychopharmacology"},{"issue":"5","key":"10.1002\/14651858.CD003196.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"408\u201312","DOI":"10.1001\/jama.1995.03520290060030","article-title":"Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials","volume":"273","author":"Schulz","year":"1995","journal-title":"Journal of American Medical Association"},{"issue":"39","key":"10.1002\/14651858.CD003196.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"iii-iv, ix-206","DOI":"10.3310\/hta11390","article-title":"A systematic review and economic model of the clinical effectiveness and cost-effectiveness of interventions for preventing relapse in people with bipolar disorder","volume":"11","author":"Soares-Weiser","year":"2007","journal-title":"Health Technology Assessment"},{"issue":"11","key":"10.1002\/14651858.CD003196.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/S0895-4356(00)00242-0","article-title":"Publication and related bias in meta-analysis: power of statistical tests and prevalence in the literature","volume":"53","author":"Sterne","year":"2000","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD003196.pub2-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1192\/pb.21.4.221","article-title":"Doses of carbamazepine and valproate in bipolar affective disorder","volume":"21","author":"Taylor","year":"1997","journal-title":"Psychiatric Bulletin"},{"issue":"12","key":"10.1002\/14651858.CD003196.pub2-BIB0076|cit76","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006528.pub2","article-title":"Mirtazapine versus other antidepressive agents for depression","author":"Watanabe","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD003196.pub2-BIB0077|cit77","first-page":"293\u20139","article-title":"Cross-national epidemiology of major depression and bipolar disorder","volume":"276","author":"Weissman","year":"1996","journal-title":"Journal of the American Medical Association"},{"key":"10.1002\/14651858.CD003196.pub2-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"182\u20138","DOI":"10.1055\/s-2000-12981","article-title":"Valproate and the symptomatic treatment of schizophrenia spectrum patients","volume":"33","author":"Winterer","year":"2000","journal-title":"Pharmacopsychiatry"},{"issue":"1","key":"10.1002\/14651858.CD003196.pub2-BIB0079|cit79","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003196","article-title":"Valproic acid, valproate and divalproex in the maintenance treatment of bipolar disorder","author":"Macritchie","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD003196.pub2\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T06:14:26Z","timestamp":1748326466000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD003196.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Common Mental Disorders Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,10,17]]},"references-count":79,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2013,10]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd003196.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10,17]]}}}